Real-World Safety and Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Asthma: Final Analysis of a Post-Marketing Surveillance in Japan
FF/UMEC/VI was well tolerated and effective in the treatment of patients with asthma in Japan. ADRs were reported in 8.4% of patients and the incidence of CV events was low. No new safety concerns were identified.
Authors
- Masaki Komatsubara
- Kazuhisa Asai (ORCID: https://orcid.org/0000-0001-8400-863X)
- Yoriko Morioka
- Risako Ito (ORCID: https://orcid.org/0009-0006-6820-0561)
- Hiroki Maruoka
Institutions
- GlaxoSmithKline (Japan) (JP)
- Data Management (Italy) (IT)
- Osaka Metropolitan University (JP)
- Tokyo Metropolitan University (JP)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1007/s12325-025-03421-2
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00